Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation

Human Pathology

Volumn 40, Issue 3, 2009, Pages 398-404

  Winn, Brody ^a   Tavares, Rosemarie ^a   Fanion, Jacqueline ^a   Noble, Lelia ^a   Gao, John ^a   Sabo, Edmond ^a   Resnick, Murray B ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Calretinin; Carcinoma; CDX2; Colon; Medullary

Indexed keywords

CALRETININ; CHROMOGRANIN; CK20 PROTEIN; CK7 PROTEIN; INTESTINAL TREFOIL FACTOR; INTESTINAL TREFOIL FACTOR 3; MUCIN 1; MUCIN 2; PARAFFIN; PROTEIN; PROTEIN MLH1; PROTEIN P53; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLARY CARCINOMA; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOMA, MEDULLARY; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 59049083733     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.08.014     Document Type: Article

References (27)

1. Ruschoff J., Dietmaier W., Luttges J., et al. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 150 (1997) 1815-1825
2. Wick M.R., Vitsky J.L., Ritter J.H., Swanson P.E., and Mills S.E. Sporadic medullary carcinoma of the colon. Am J Clin Pathol 123 (2005) 56-65
3. Jessurun J., Romero-Guadarrama M., and Manivel J.C. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol 30 (1999) 843-848
4. Sugao Y., Yao T., Kubo C., and Tsuneyoshi M. Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study. Histopathology 31 (1997) 123-133
5. Lanza G., Gara R., Matteuzzi M., and Santini A. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol 17 (1999) 2429-2438
6. Hinoi T., Tani M., Lucas P.C., et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 159 (2001) 2239-2248
7. Arai T., Esaki Y., Sawabe M., Honma N., Nakamura K., and Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 17 (2004) 172-179
8. Gotzos V., Wintergerst E., Musy J.P., Spichtin H.P., and Genton C.Y. Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol 23 (1999) 701-711
9. Podolsky D.K., Lynch-Devaney K., Stow J.L., et al. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268 (1993) 6694-6702
10. Nakamori S., Ota D.M., Cleary K.R., Shirotani K., and Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106 (1994) 353-361
11. Tytgat K.M., Buller H.A., Opdam F.J., Kim Y.S., Einerhand A.W., and Dekker J. Biosynthesis of human colonic mucin: MUC2 is the prominent secretory mucin. Gastroenterology 107 (1994) 1352-1363
12. Hamilton S.R., Vogelstein B., Kudo S., et al. Carcinoma of the colon and rectum. In: Hamilton S.R., and Aaltonen L. (Eds). World Health Organization Classification of Tumors: Pathology and Genetics. Tumors of the Digestive System (2000), IARC Press, Lyon (France) 103-142
13. Lafontaine P.O., Arnal M., Buron N., et al. Trefoil factor family mRNA and protein expression in pterygium. Int J Oncol 27 (2005) 997-1003
14. Resnick M.B., Routhier J., Konkin T., Sabo E., and Pricolo V. Epidermal growth factor receptor, c-MET, beta-catenin and p53 expression in stage II colon cancer: a tissue microarray study. Clin Cancer Res 10 (2004) 3069-3075
15. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
16. Alexander J., Watanabe T., Wu T.T., Rashid A., Li S., and Hamilton S.R. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158 (2001) 527-535
17. Rogers J.H. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105 (1987) 1343-1353
18. Cargnello R., Celio M.R., Schwaller B., and Gotzos V. Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation. Biochim Biophys Acta 1313 (1996) 201-208
19. Drummond F., Putt W., Fox M., et al. Cloning and chromosome assignment of the human CDX2 gene. Ann Hum Genet 61 (1997) 393-400
20. Werling R.W., Yaziji H., Bacchi C.E., and Gown A.M. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin. Am J Surg Pathol 27 (2003) 303-310
21. De Lott L.B., Morrison C., Suster S., Cohn D.E., and Frankel W.L. CDX2 is a useful marker of intestinal type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med 129 (2005) 1100-1105
22. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8 (1995) 384-388
23. Dignass A., Lynch-Devaney K., Kindon H., Thim L., and Podolsky D. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94 (1995) 376-383
24. Taupin D., Ooi K., Yeomans N., and Giraud A. Conserved expression of intestinal trefoil factor in the an colonic adenoma-carcinoma sequence. Lab Invest 75 (1996) 25-32
25. Yio X., Zhang J., Babyatsky M., et al. Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells. Clin Exp Metastasis 22 (2005) 157-165
26. Ajioka Y., Allison L.J., and Jass J.R. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol 49 (1996) 560-564
27. Blank M., Klussmann E., Kruger-Krasagakes S., et al. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59 (1994) 301-306